1271-1278
Review
Toll-like receptors expressed in tumor cells: targets for therapy
Li Yu and Shangwu Chen
1279-1289
Original Article
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
Robert M. Prins, Chengyi J. Shu, Caius G. Radu, Dan D. Vo and Haumith Khan-Farooqi, et al.
1291-1300
Original Article
Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses
Stephan Roux, Claire Bernat, Bassim Al-Sakere, François Ghiringhelli and Paule Opolon, et al.
1301-1313
Original Article
Development of a Listeria monocytogenes based vaccine against prostate cancer
Vafa Shahabi, Mariela Reyes-Reyes, Anu Wallecha, Sandra Rivera and Yvonne Paterson, et al.
1315-1321
Original Article
Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma
Wenjun Wang, Howard D. Edington, Drazen M. Jukic, Uma N. M. Rao and Stephanie R. Land, et al.
1323-1333
Original Article
Experimental manipulations of afferent immune responses influence efferent immune responses to brain tumors
Diana L. Thomas, David M. Kranz and Edward J. Roy
1335-1345
Original Article
High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-α in lung cancer
R. B. Baleeiro, L. B. Anselmo, F. A. Soares, C. A. L. Pinto and O. Ramos, et al.
1347-1355
Original Article
Investigation of the mechanisms of tissue factor-mediated evasion of tumour cells from cellular cytotoxicity
Chao Li, Mary E. W. Collier, G. Alkisitis Frentzou, John Greenman and Camille Ettelaie
1357-1365
Original Article
Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer
Stephanie S. Tseng-Rogenski, Mohamed S. Arredouani, Yilin C. Neeley, Bin Lu and Arul M. Chinnaiyan, et al.
1367-1379
Original Article
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
Michele C. Madigan, Elizabeth A. Kingsley, Paul J. Cozzi, Warick J. Delprado and Pamela J. Russell, et al.
1381-1390
Original Article
CD54 is a surrogate marker of antigen presenting cell activation
N. A. Sheikh and L. A. Jones
1391-1398
Original Article
Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design
Maciej Kmieciak, Johanna K. Morales, Joshua Morales, Elizabeth Bolesta and Margaret Grimes, et al.
1399-1411
Original Article
TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model
Hiroyuki Inoue, Mutsunori Iga, Meng Xin, Saori Asahi and Takafumi Nakamura, et al.
1413-1420
Original Article
Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
Antoun Toubaji, Moujahed Achtar, Maurizio Provenzano, Vincent E. Herrin and Robert Behrens, et al.
1421-1427
Meeting Report
Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007
V. Schirrmacher, P. Beckhove, P. Fournier and V. Umansky